Shivanand Lad

Lad

Professor of Neurosurgery

Dr. Nandan Lad is a neurosurgeon, scientist, and entrepreneur and an Associate Professor at Duke University Medical Center with a focus in Neuromodulation and Neurorestoration.  He is Director of the Duke NeuroInnovations Program, a systematic approach to medical device innovation to large unmet clinical needs.

He completed his MD and PhD in Biochemistry at Chicago Medical School and his neurosurgical residency training at Stanford with fellowships in Surgical Innovation and Functional Neurosurgery.  

Neuromodulation; Neurorestoration; Bioengineering; Medical Device Design; Clinical Trials; Data Science; Health Outcomes.

Appointments and Affiliations

  • Professor of Neurosurgery
  • Associate Professor in the Department of Mechanical Engineering and Materials Science
  • Faculty Network Member of the Duke Institute for Brain Sciences
  • Core Faculty in Innovation & Entrepreneurship
  • Core Faculty Member, Duke-Margolis Center for Health Policy

Contact Information

Education

  • Stanford University, 2009
  • Stanford University, 2008
  • Stanford University, 2011
  • Stanford University, 2005
  • Ph.D. Rosalind Franklin University of Medicine and Science, 2004
  • M.D. Rosalind Franklin University of Medicine and Science, 2004

Research Interests

Neurotrophin biology, neuroregeneration, medical device design

Courses Taught

  • NEUROSCI 391: Neuroscience Independent Scholarship 1: Advanced Topics

In the News

Representative Publications

  • Williamson, TL; Adil, SM; Shalita, C; Charalambous, LT; Mitchell, T; Yang, Z; Parente, BA; Lee, H-J; Ubel, PA; Lemmon, ME; Galanos, AN; Lad, SP; Komisarow, JM, Palliative Care Consultations in Patients with Severe Traumatic Brain Injury: Who Receives Palliative Care Consultations and What Does that Mean for Utilization?, Neurocritical Care, vol 36 no. 3 (2022), pp. 781-790 [10.1007/s12028-021-01366-2] [abs].
  • Venkatraman, V; Ponder, M; Gellad, ZF; Lad, SP; Christy, E; Plichta, R; Harrison, JK; Hughes, GC; Doberne, J, Feasibility study of a novel digital health platform for patients undergoing transcatheter aortic valve replacement., J Card Surg (2022) [10.1111/jocs.16515] [abs].
  • Petersen, EA; Stauss, TG; Scowcroft, JA; Brooks, ES; White, JL; Sills, SM; Amirdelfan, K; Guirguis, MN; Xu, J; Yu, C; Nairizi, A; Patterson, DG; Tsoulfas, KC; Creamer, MJ; Galan, V; Bundschu, RH; Mehta, ND; Sayed, D; Lad, SP; DiBenedetto, DJ; Sethi, KA; Goree, JH; Bennett, MT; Harrison, NJ; Israel, AF; Chang, P; Wu, PW; Argoff, CE; Nasr, CE; Taylor, RS; Caraway, DL; Mekhail, NA, Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial., Diabetes Care, vol 45 no. 1 (2022), pp. e3-e6 [10.2337/dc21-1813] [abs].
  • Gilligan, C; Volschenk, W; Russo, M; Green, M; Gilmore, C; Mehta, V; Deckers, K; De Smedt, K; Latif, U; Georgius, P; Gentile, J; Mitchell, B; Langhorst, M; Huygen, F; Baranidharan, G; Patel, V; Mironer, E; Ross, E; Carayannopoulos, A; Hayek, S; Gulve, A; Van Buyten, J-P; Tohmeh, A; Fischgrund, J; Lad, S; Ahadian, F; Deer, T; Klemme, W; Rauck, R; Rathmell, J; Maislin, G; Heemels, JP; Eldabe, S; ReActiv8-B Investigators,, Long-Term Outcomes of Restorative Neurostimulation in Patients With Refractory Chronic Low Back Pain Secondary to Multifidus Dysfunction: Two-Year Results of the ReActiv8-B Pivotal Trial., Neuromodulation (2021) [10.1016/j.neurom.2021.10.011] [abs].
  • Gilligan, C; Volschenk, W; Russo, M; Green, M; Gilmore, C; Mehta, V; Deckers, K; De Smedt, K; Latif, U; Georgius, P; Gentile, J; Mitchell, B; Langhorst, M; Huygen, F; Baranidharan, G; Patel, V; Mironer, E; Ross, E; Carayannopoulos, A; Hayek, S; Gulve, A; Van Buyten, J-P; Tohmeh, A; Fischgrund, J; Lad, S; Ahadian, F; Deer, T; Klemme, W; Rauck, R; Rathmell, J; Levy, R; Heemels, JP; Eldabe, S; ReActiv8-B investigators,, An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial., Pain, vol 162 no. 10 (2021), pp. 2486-2498 [10.1097/j.pain.0000000000002258] [abs].